2-(1,3-benzodioxol-5-yl)-2-methylpropanal | 857817-36-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并间二氧杂环戊烯类
• 英文名称: 2-(1,3-benzodioxol-5-yl)-2-methylpropanal
• 英文别名: 2-benzo[1,3]dioxol-5-yl-2-methyl-propionaldehyde；2-(1,3-Benzodioxol-5-yl)-2-methyl propanal
• CAS: 857817-36-8
• 化学式: C₁₁H₁₂O₃
• 分子量: 192.214
• InChiKey: ACPIOQKVNYLGJL-UHFFFAOYSA-N

物化性质

• 沸点：
  286.7±29.0 °C(Predicted)
• 密度：
  1.167±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(1,3-benzodioxol-5-yl)-2-methylpropanal 在 羟胺 作用下， 生成 2-benzo[1,3]dioxol-5-yl-2-methyl-propionaldehyde oxime
  参考文献：
  名称：

  Tiffeneau; Levy, Bulletin de la Societe Chimique de France, 1931, vol. <4> 49, p. 1738,1746

  摘要：

  DOI：
• 作为产物：
  描述：

  methyl 2-(1,3-benzodioxol-5-yl)-2-methyl propanoate 在 lithium aluminium tetrahydride 、 pyridinium chlorochromate 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 2-(1,3-benzodioxol-5-yl)-2-methylpropanal
  参考文献：
  名称：

  SUBSTITUTED CATHECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA

  摘要：

  本发明涉及通式1的化合物，用于通过抑制IL-4或IL-5途径的抑制治疗支气管哮喘。本发明还涉及使用通式1的化合物通过抑制IL-4或IL-5途径的抑制治疗支气管哮喘。本发明还涉及通过口服、鼻内、或吸入途径向需要治疗的哺乳动物给予化合物或所述组合物来抑制IL-4或IL-5途径以治疗哮喘的方法。通式1的化合物可用于减少周围血管和支气管炎症。

  公开号：

  US20140135393A1

文献信息

• Palladium-Catalyzed Site-Selective C(sp³)–H Arylation of Phenylacetaldehydes
  作者：Bo-Bo Gou、Hang-Fan Liu、Jie Chen、Ling Zhou

  DOI：10.1021/acs.orglett.9b02650

  日期：2019.9.6

  describe a Pd-catalyzed selective C-H arylation reaction of phenylacetaldehydes using l-valine as the transient directing group. This process showed a broad substrate scope and excellent selectivity in which a ligand-controlled functionalization of the unactivated β-C(sp3)-H bond. In addition, enantioselective arylation of phenylacetaldehydes was preliminarily explored by utilizing a bulky chiral transient

  我们描述了使用L-缬氨酸作为瞬时导向基团的Pd催化的苯乙醛的选择性CH芳基化反应。此过程显示出广泛的底物范围和出色的选择性，其中未活化的β-C（sp3）-H键的配体控制功能化。此外，通过利用庞大的手性瞬态导向基团初步研究了苯乙醛的对映选择性芳基化。
• [EN] INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO)<br/>[FR] INHIBITEURS DE LA PHOSPHATIDYLINOSITOL-3-KINASE (PI3) ET INDUCTEURS D'OXYDE NITRIQUE (NO)
  申请人：COUNCIL SCIENT IND RES

  公开号：WO2010079423A1

  公开（公告）日：2010-07-15

  The present invention relates to compounds of general formula 1 for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention also relates to the use of compound of general formula 1 for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention further relates to a method of treating malignancy by inhibition of PI3-Akt pathway and or induction of NO by administration of compound or said composition to a mammal in need thereof.

  本发明涉及通式1的化合物，通过抑制PI3-Akt通路和/或诱导NO来治疗恶性肿瘤。本发明还涉及使用通式1的化合物通过抑制PI3-Akt通路和/或诱导NO来治疗恶性肿瘤。本发明还涉及通过向需要该治疗的哺乳动物给予该化合物或该组合物来抑制PI3-Akt通路和/或诱导NO治疗恶性肿瘤的方法。
• INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO)
  申请人：Bandyopadhyay Santu

  公开号：US20120190738A1

  公开（公告）日：2012-07-26

  The present invention relates to compounds of general formula I for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention also relates to the use of compound of general formula I for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention further relates to a method of treating malignancy by inhibition of PI3-Akt pathway and or induction of NO by administration of compound or said composition to a mammal in need thereof.

  本发明涉及一般式I的化合物，通过抑制PI3-Akt途径和/或诱导NO治疗恶性肿瘤。本发明还涉及使用一般式I的化合物通过抑制PI3-Akt途径和/或诱导NO治疗恶性肿瘤。本发明还涉及一种通过向需要该治疗的哺乳动物给予化合物或所述组合物来抑制PI3-Akt途径和/或诱导NO治疗恶性肿瘤的方法。
• 2,5-DI- and 2,2,5-Trisubstituted Di- and Tetrahydrofuran Derivatives and Their Use for the Production of Perfumes
  申请人：Kraft Philip

  公开号：US20100173999A1

  公开（公告）日：2010-07-08

  Di-/trisubstituted furans of the formula (I) and their use as odorants wherein R 1 is hydrogen or methyl; R 2 is ethyl, propyl or isopropyl; the bond between C-3 and C-4 is a single bond, or the dotted line together with the bond between C-3 and C-4 represents a double bond; and the bond between C-4′ and C-5′ is a single bond, or the dotted line together with the bond between C-4′ and C-5′ represents a double bond, either in (E)- or (Z)-configuration. The invention furthermore relates to a method of their production and to perfume compositions comprising them.

  公式（I）的二/三取代呋喃化合物及其作为香味剂的用途，其中R1为氢或甲基；R2为乙基、丙基或异丙基；C-3和C-4之间的键为单键，或者虚线与C-3和C-4之间的键一起表示双键；C-4'和C-5'之间的键为单键，或者虚线与C-4'和C-5'之间的键一起表示双键，可以是（E）或（Z）构型。此发明还涉及它们的制备方法和包含它们的香水组合物。
• Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO)
  申请人：Bandyopadhyay Santu

  公开号：US09290473B2

  公开（公告）日：2016-03-22

  The present invention relates to compounds of general formula 1 for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention also relates to the use of compound of general formula 1 for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention further relates to a method of treating malignancy by inhibition of PI3-Akt pathway and or induction of NO by administration of compound or said composition to a mammal in need thereof.

  本发明涉及通式1的化合物，用于通过抑制PI3-Akt通路和/或诱导NO治疗恶性肿瘤。本发明还涉及使用通式1的化合物通过抑制PI3-Akt通路和/或诱导NO治疗恶性肿瘤。本发明还涉及一种通过向需要的哺乳动物给予化合物或所述组合物来通过抑制PI3-Akt通路和/或诱导NO治疗恶性肿瘤的方法。